Metraipolis › archive › dc_bbae7a696027
Treating Unmet Needs in Psychiatry (TUNE-UP): A Targeted Service Increases Outpatient Initiations of Clozapine — Europe PMC PPR:PPR1001222
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR1001222
- DOI
- 10.1101/2025.04.04.25325236
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T11:59:37.172Z
- SHA-256 of the archived text
771c776d15ca9074fb9d40fd56d11349adc2a6b1107e7875915a5f0282c15cb6- Stable URL of this page
https://metraipolis.com/documento/dc_bbae7a696027
How to cite
Treating Unmet Needs in Psychiatry (TUNE-UP): A Targeted Service Increases Outpatient Initiations of Clozapine — Europe PMC PPR:PPR1001222 — Europe PMC, https://europepmc.org/article/PPR/PPR1001222 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_bbae7a696027 (Metraipolis archive dc_bbae7a696027, sha256 771c776d15ca9074fb9d40fd56d11349adc2a6b1107e7875915a5f0282c15cb6)
BibTeX
@misc{dcbbae7a696027,
title = {Treating Unmet Needs in Psychiatry (TUNE-UP): A Targeted Service Increases Outpatient Initiations of Clozapine — Europe PMC PPR:PPR1001222},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR1001222},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_bbae7a696027; sha256 771c776d15ca9074fb9d40fd56d11349adc2a6b1107e7875915a5f0282c15cb6},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR1001222. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Up to one-third of patients with schizophrenia do not benefit from standard antipsychotic treatment – termed treatment-resistant schizophrenia (TRS). Clozapine is the only licensed treatment in TRS and is associated with better outcomes. However, it is underused, as its initiation is often limited by the need for inpatient admission, which is costly and unattractive to patients. Community clozapine titration services may address this. Aims: To describe a targeted outpatient clinic (TUNE-UP) for TRS management and assess its impact on clozapine initiation rates. Method: We reviewed clozapine titrations for patients under four community mental health teams in the United Kingdom from September 2021 to January 2025, noting whether titration occurred in inpatient or outpatient settings. The TUNE-UP clozapine clinic operated for 12 months (September 2023 to September 2024). Initiation rates during the TUNE-UP period were compared with rates when the service was unavailable using Poisson regression. Clinical outcomes were assessed using scales such as the Positive and Negative Syndrome Scale (PANSS) for symptom severity and the Social and Occupational Functioning Assessment Scale (SOFAS) for functioning. Results: 61 individuals were commenced on clozapine. During the TUNE-UP clinic’s operation, community initiation rates increased to 11.0 per year (up from 1.33 per year when the service was unavailable), while inpatient initiations were similar (11.0 per year vs. 11.67 per year). Increases in total initiations (p = 0.048) and community initiations (p = 0.0003) were statistically significant. Patients seen by TUNE-UP had improvements in PANSS (mean baseline 63.3 (SD 18.3); mean improvement 20.5 (SD 12.2; p = 0.009)), and SOFAS (mean baseline 48.3 (SD 7.5); mean improvement 8.8 (SD 7.1, p = 0.028)). Conclusion: A specialist community service was associated with a significant increase in clozapine initiations alongside improved clinical outcomes. This approach offers a clinically and cost-effective strategy to enhance treatment for TRS. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: medRxiv, 2025 (prima pubblicazione 2025-04-04). Identificativi: DOI 10.1101/2025.04.04.25325236. Pagina: https://europepmc.org/article/PPR/PPR1001222 — https://doi.org/10.1101/2025.04.04.25325236. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T10:21:17.955Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.